Multimodal Neuroimaging for the PK/PD Profile of NLX-204: A Biased 5-HT 1A Receptor Agonist
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00342 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Violette Richin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lyon Neuroscience Research Center, Université Claude Bernard Lyon 1, Inserm, CNRS, 69500 Bron, France. Hauptthemen laut MEDLINE: Serotonin 5-HT1 Receptor Agonists, Brain, Receptor, Serotonin, 5-HT1A, Neuroimaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Université de Lyon, Neurolixis SAS.
Abstract (Originalsprache)
NLX-204, a highly selective biased agonist for serotonin 5-HT1A receptors, demonstrates strong affinity and preferentially elicits ERK1/2 phosphorylation, a response linked to antidepressant activity. Preclinical studies in rodent models confirm its potential as an effective and rapid-acting treatment for depression. In the present study, we performed a pharmacokinetic and pharmacodynamic characterization of NLX-204 by means of neuroimaging techniques. Radiolabeling of NLX-204 with fluorine-18 was used to assess its brain distribution and labeling kinetics via PET microdosing imaging in rats. Its pharmacodynamics were further investigated through a dose-response study in awake, freely moving rats using functional ultrasound (fUS) imaging. This unique combination of PET and fUS brain imaging data demonstrates that NLX-204 specifically engages 5-HT1A receptors in the rat brain, eliciting robust activation in specific cortical regions. These results support the potential of NLX-204 as a promising candidate for the treatment of mood disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lyon Neuroscience Research Center, Université Claude Bernard Lyon 1, Inserm, CNRS, 69500 Bron, France.
- Neurolixis, 81100 Castres, France.
- CERMEP, Imaging Platform, 69500 Bron, France.
- Hospices Civils de Lyon, 69002 Lyon, France.
ORCID-Profile: Violette Richin, Adrian Newman-Tancredi, Wael Zeinyeh, Luc Zimmer
Förderung
- Université de Lyon
- Neurolixis SAS
Zitieren
APA
Richin, V., Valdebenito, M., Bouillot, C., Bouvard, S., Daligault, S., Vidal, B., Newman-Tancredi, A., Zeinyeh, W., & Zimmer, L. (2025). Multimodal Neuroimaging for the PK/PD Profile of NLX-204: A Biased 5-HT 1A Receptor Agonist. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00342
Vancouver
Richin V, Valdebenito M, Bouillot C, Bouvard S, Daligault S, Vidal B, et al. Multimodal Neuroimaging for the PK/PD Profile of NLX-204: A Biased 5-HT 1A Receptor Agonist. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00342
BibTeX
@article{Richin2025,
author = {Richin, Violette and Valdebenito, Marco and Bouillot, Caroline and Bouvard, Sandrine and Daligault, Sébastien and Vidal, Benjamin and Newman-Tancredi, Adrian and Zeinyeh, Wael and Zimmer, Luc},
title = {Multimodal Neuroimaging for the PK/PD Profile of NLX-204: A Biased 5-HT 1A Receptor Agonist},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00342}
}
EUVIMED